Northwest Biotherapeutics Acquires Flaskworks

Northwest Biotherapeutics Acquires Advent BioServices (DCVax Manufacturing Scale-Up)

October 26, 2025

Biotechnology

Northwest Biotherapeutics (NWBio) has completed its acquisition of Advent BioServices Ltd., with Advent becoming a wholly owned subsidiary. The deal is intended to create a more integrated manufacturing and operations platform to scale production of NWBio’s DCVax immunotherapy products, including facilitating consolidation of facilities and reallocation of resources to Sawston and capacity expansion in the United States.

Illumina Acquires Fluent BioSciences

July 9, 2024

Biotechnology

Illumina, Inc. has acquired Fluent BioSciences to integrate Fluent's PIPseq single-cell technology into Illumina's product portfolio and accelerate its multiomics capabilities. The acquisition, which closed July 9, 2024 and was funded with cash on hand, brings Fluent's accessible, scalable single-cell chemistry and the Fluent team into Illumina to expand end-to-end single-cell solutions for research and applied customers.

Ajinomoto Co., Inc. Acquires Forge Biologics

November 13, 2023

Biotechnology

Ajinomoto Co., Inc. will acquire Forge Biologics in an all-cash transaction valued at $620 million, expanding Ajinomoto's gene therapy and plasmid/AAV manufacturing capabilities. Forge, a Columbus, Ohio–based viral vector and plasmid CDMO with a 200,000 sq ft cGMP facility and ~300+ employees, will become a consolidated subsidiary to accelerate global gene and cell therapy manufacturing capacity.

ProMach Acquires Pharmaworks

March 9, 2020

Packaging

ProMach has acquired Pharmaworks, a Florida-based provider of blister packaging and thermoforming machinery, expanding ProMach's pharmaceutical packaging capabilities and integrated solutions. Pharmaworks’ team of over 100 employees and its lineup of blister packaging systems, inspection, and aftermarket services will join ProMach’s pharma business line to broaden its product offering and support for pharmaceutical, consumer goods, and contract packaging customers.

New England Biolabs Acquires Fluorogenics Limited

May 10, 2021

Biotechnology

New England Biolabs (NEB) has agreed to acquire Fluorogenics Limited (FGL), a UK-based lyophilization R&D and ISO 13485-certified service provider. FGL will become a wholly owned subsidiary of NEB as NEB integrates lyophilization capabilities into its OEM and Customized Solutions offering to better serve molecular and point-of-care diagnostics customers.

CELLTREAT Scientific Products Acquires Brewster Plastics

November 13, 2024

Manufacturing

CELLTREAT Scientific Products has acquired Brewster Plastics, a U.S.-based precision injection molding manufacturer with a 72,000 sq. ft. facility in Patterson, New York. Operations will be consolidated with CELLTREAT's VistaLab Technologies subsidiary to expand domestic production capacity, improve delivery times, and boost manufacturing efficiency for lab consumables and plastics.